SCHEMBL31411478

SCHEMBL31411478

C=Cc1n[nH]c2c(F)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 3/20 0.36
▸ GPR84 Q9NQS5 1/20 0.36
▸ AR P10275 3/20 0.33
▸ MPO P05164 3/20 0.33
▸ SLC6A4 P31645 3/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ PLK3 Q9H4B4 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ CDK4 P11802 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCND3 P30281 1/20 0.32
▸ MAP4K4 O95819 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ FGFR1 P11362 1/20 0.31
▸ PDGFRA P16234 1/20 0.31
▸ LTK P29376 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29952281 0.82 AR (0.36) CHEK1GPR84ARMPOSLC6A4
SCHEMBL786302 0.73 CHEK1 (0.60) CHEK1GPR84ARMPOSLC6A4
SCHEMBL30998058 0.72 AR (0.38) GPR84ARMPOSLC6A4MAPK10
SCHEMBL31539823 0.72 CHEK1 (0.44) CHEK1GPR84ARMPOSLC6A4
SCHEMBL4234184 0.72 ADORA2A (0.41) CHEK1GPR84ARMPOSLC6A4
SCHEMBL11903870 0.72 GPR84 (0.39) CHEK1GPR84ARMPOSLC6A4
SCHEMBL14158301 0.72 CHEK1 (0.40) CHEK1GPR84ARMPOSLC6A4
SCHEMBL14158228 0.72 GPR84 (0.39) CHEK1GPR84ARMPOSLC6A4
SCHEMBL31411346 0.71 CHEK1 (0.39) CHEK1GPR84FLT3MAPK10FEN1
SCHEMBL31190846 0.69 KDM4E (0.52) CHEK1FLT3MAPK10RIPK1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 — — US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 — — US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 — — US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB CHEK1 2942/4885GPR84 3280/4885AR 3574/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB CHEK1 2942/4885GPR84 3280/4885AR 3574/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB CHEK1 2942/4885GPR84 3280/4885AR 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback